nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—GRIN2B—Alzheimer's disease	0.314	1	CbGaD
Felbamate—GRIN2B—Memantine—Alzheimer's disease	0.167	0.348	CbGbCtD
Felbamate—GRIN2A—Memantine—Alzheimer's disease	0.167	0.348	CbGbCtD
Felbamate—GRIN3A—Memantine—Alzheimer's disease	0.111	0.231	CbGbCtD
Felbamate—CYP2C19—Memantine—Alzheimer's disease	0.0135	0.0282	CbGbCtD
Felbamate—CYP3A4—Rivastigmine—Alzheimer's disease	0.00942	0.0197	CbGbCtD
Felbamate—CYP3A4—Donepezil—Alzheimer's disease	0.00753	0.0157	CbGbCtD
Felbamate—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.00603	0.24	CbGeAlD
Felbamate—CYP3A4—Galantamine—Alzheimer's disease	0.00485	0.0101	CbGbCtD
Felbamate—GRIN3A—forebrain—Alzheimer's disease	0.00174	0.0694	CbGeAlD
Felbamate—GRIN3A—telencephalon—Alzheimer's disease	0.0016	0.0638	CbGeAlD
Felbamate—GRIN2B—forebrain—Alzheimer's disease	0.00158	0.0628	CbGeAlD
Felbamate—GRIN2B—telencephalon—Alzheimer's disease	0.00145	0.0577	CbGeAlD
Felbamate—GRIN2A—forebrain—Alzheimer's disease	0.00138	0.0549	CbGeAlD
Felbamate—GRIN2A—telencephalon—Alzheimer's disease	0.00127	0.0505	CbGeAlD
Felbamate—GRIN3A—nervous system—Alzheimer's disease	0.000946	0.0377	CbGeAlD
Felbamate—GRIN3A—central nervous system—Alzheimer's disease	0.00091	0.0363	CbGeAlD
Felbamate—GRIN2B—nervous system—Alzheimer's disease	0.000855	0.0341	CbGeAlD
Felbamate—GRIN2B—central nervous system—Alzheimer's disease	0.000823	0.0328	CbGeAlD
Felbamate—GRIN2B—cerebellum—Alzheimer's disease	0.000805	0.0321	CbGeAlD
Felbamate—GRIN2A—nervous system—Alzheimer's disease	0.000748	0.0298	CbGeAlD
Felbamate—GRIN3A—brain—Alzheimer's disease	0.000723	0.0288	CbGeAlD
Felbamate—GRIN2A—central nervous system—Alzheimer's disease	0.00072	0.0287	CbGeAlD
Felbamate—GRIN2A—cerebellum—Alzheimer's disease	0.000703	0.028	CbGeAlD
Felbamate—GRIN2B—brain—Alzheimer's disease	0.000654	0.026	CbGeAlD
Felbamate—Lacosamide—CA4—Alzheimer's disease	0.000593	1	CrCbGaD
Felbamate—GRIN2A—brain—Alzheimer's disease	0.000571	0.0228	CbGeAlD
Felbamate—CYP2E1—telencephalon—Alzheimer's disease	0.00039	0.0155	CbGeAlD
Felbamate—CYP2E1—nervous system—Alzheimer's disease	0.00023	0.00917	CbGeAlD
Felbamate—CYP2E1—central nervous system—Alzheimer's disease	0.000222	0.00883	CbGeAlD
Felbamate—CYP2E1—cerebellum—Alzheimer's disease	0.000217	0.00863	CbGeAlD
Felbamate—CYP3A4—nervous system—Alzheimer's disease	0.000185	0.00738	CbGeAlD
Felbamate—CYP3A4—central nervous system—Alzheimer's disease	0.000178	0.0071	CbGeAlD
Felbamate—CYP2E1—brain—Alzheimer's disease	0.000176	0.00701	CbGeAlD
Felbamate—Epistaxis—Donepezil—Alzheimer's disease	0.000146	0.0012	CcSEcCtD
Felbamate—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000145	0.00119	CcSEcCtD
Felbamate—Anaemia—Galantamine—Alzheimer's disease	0.000145	0.00119	CcSEcCtD
Felbamate—Dysuria—Rivastigmine—Alzheimer's disease	0.000145	0.00119	CcSEcCtD
Felbamate—Weight increased—Memantine—Alzheimer's disease	0.000144	0.00118	CcSEcCtD
Felbamate—Agitation—Galantamine—Alzheimer's disease	0.000144	0.00118	CcSEcCtD
Felbamate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000144	0.00118	CcSEcCtD
Felbamate—Weight decreased—Memantine—Alzheimer's disease	0.000143	0.00117	CcSEcCtD
Felbamate—Hyperglycaemia—Memantine—Alzheimer's disease	0.000143	0.00117	CcSEcCtD
Felbamate—Bradycardia—Donepezil—Alzheimer's disease	0.000142	0.00116	CcSEcCtD
Felbamate—Pneumonia—Memantine—Alzheimer's disease	0.000142	0.00116	CcSEcCtD
Felbamate—Malaise—Galantamine—Alzheimer's disease	0.000141	0.00116	CcSEcCtD
Felbamate—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000141	0.00116	CcSEcCtD
Felbamate—Weight increased—Rivastigmine—Alzheimer's disease	0.000141	0.00115	CcSEcCtD
Felbamate—Depression—Memantine—Alzheimer's disease	0.000141	0.00115	CcSEcCtD
Felbamate—Haemoglobin—Donepezil—Alzheimer's disease	0.00014	0.00115	CcSEcCtD
Felbamate—Weight decreased—Rivastigmine—Alzheimer's disease	0.00014	0.00115	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00014	0.00115	CcSEcCtD
Felbamate—Rhinitis—Donepezil—Alzheimer's disease	0.00014	0.00115	CcSEcCtD
Felbamate—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00014	0.00114	CcSEcCtD
Felbamate—Haemorrhage—Donepezil—Alzheimer's disease	0.000139	0.00114	CcSEcCtD
Felbamate—Hepatitis—Donepezil—Alzheimer's disease	0.000139	0.00114	CcSEcCtD
Felbamate—Pneumonia—Rivastigmine—Alzheimer's disease	0.000139	0.00114	CcSEcCtD
Felbamate—Hallucination—Donepezil—Alzheimer's disease	0.000139	0.00114	CcSEcCtD
Felbamate—Palpitations—Galantamine—Alzheimer's disease	0.000138	0.00114	CcSEcCtD
Felbamate—Pharyngitis—Donepezil—Alzheimer's disease	0.000138	0.00113	CcSEcCtD
Felbamate—Depression—Rivastigmine—Alzheimer's disease	0.000137	0.00113	CcSEcCtD
Felbamate—Urinary tract infection—Memantine—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Felbamate—Conjunctivitis—Memantine—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Felbamate—Cough—Galantamine—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Felbamate—Hypertension—Galantamine—Alzheimer's disease	0.000135	0.00111	CcSEcCtD
Felbamate—Haematuria—Memantine—Alzheimer's disease	0.000134	0.0011	CcSEcCtD
Felbamate—Visual impairment—Donepezil—Alzheimer's disease	0.000134	0.0011	CcSEcCtD
Felbamate—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000134	0.0011	CcSEcCtD
Felbamate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000134	0.0011	CcSEcCtD
Felbamate—Arthralgia—Galantamine—Alzheimer's disease	0.000133	0.00109	CcSEcCtD
Felbamate—Chest pain—Galantamine—Alzheimer's disease	0.000133	0.00109	CcSEcCtD
Felbamate—Myalgia—Galantamine—Alzheimer's disease	0.000133	0.00109	CcSEcCtD
Felbamate—Epistaxis—Memantine—Alzheimer's disease	0.000133	0.00109	CcSEcCtD
Felbamate—Anxiety—Galantamine—Alzheimer's disease	0.000133	0.00109	CcSEcCtD
Felbamate—Sinusitis—Memantine—Alzheimer's disease	0.000132	0.00109	CcSEcCtD
Felbamate—Sweating—Rivastigmine—Alzheimer's disease	0.000132	0.00108	CcSEcCtD
Felbamate—Discomfort—Galantamine—Alzheimer's disease	0.000132	0.00108	CcSEcCtD
Felbamate—Agranulocytosis—Memantine—Alzheimer's disease	0.000132	0.00108	CcSEcCtD
Felbamate—Haematuria—Rivastigmine—Alzheimer's disease	0.000131	0.00108	CcSEcCtD
Felbamate—Dry mouth—Galantamine—Alzheimer's disease	0.00013	0.00107	CcSEcCtD
Felbamate—Epistaxis—Rivastigmine—Alzheimer's disease	0.00013	0.00107	CcSEcCtD
Felbamate—Sinusitis—Rivastigmine—Alzheimer's disease	0.000129	0.00106	CcSEcCtD
Felbamate—Confusional state—Galantamine—Alzheimer's disease	0.000129	0.00106	CcSEcCtD
Felbamate—Bradycardia—Memantine—Alzheimer's disease	0.000129	0.00106	CcSEcCtD
Felbamate—Haemoglobin—Memantine—Alzheimer's disease	0.000127	0.00104	CcSEcCtD
Felbamate—Rhinitis—Memantine—Alzheimer's disease	0.000127	0.00104	CcSEcCtD
Felbamate—Hepatitis—Memantine—Alzheimer's disease	0.000127	0.00104	CcSEcCtD
Felbamate—Haemorrhage—Memantine—Alzheimer's disease	0.000127	0.00104	CcSEcCtD
Felbamate—Bradycardia—Rivastigmine—Alzheimer's disease	0.000126	0.00103	CcSEcCtD
Felbamate—Hallucination—Memantine—Alzheimer's disease	0.000126	0.00103	CcSEcCtD
Felbamate—Pharyngitis—Memantine—Alzheimer's disease	0.000126	0.00103	CcSEcCtD
Felbamate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000125	0.00103	CcSEcCtD
Felbamate—Chills—Donepezil—Alzheimer's disease	0.000125	0.00103	CcSEcCtD
Felbamate—Tachycardia—Galantamine—Alzheimer's disease	0.000125	0.00102	CcSEcCtD
Felbamate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000124	0.00102	CcSEcCtD
Felbamate—Rhinitis—Rivastigmine—Alzheimer's disease	0.000124	0.00102	CcSEcCtD
Felbamate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000124	0.00102	CcSEcCtD
Felbamate—Hepatitis—Rivastigmine—Alzheimer's disease	0.000124	0.00102	CcSEcCtD
Felbamate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000124	0.00101	CcSEcCtD
Felbamate—Hallucination—Rivastigmine—Alzheimer's disease	0.000123	0.00101	CcSEcCtD
Felbamate—Alopecia—Donepezil—Alzheimer's disease	0.000123	0.00101	CcSEcCtD
Felbamate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000123	0.00101	CcSEcCtD
Felbamate—Visual impairment—Memantine—Alzheimer's disease	0.000122	0.001	CcSEcCtD
Felbamate—Anorexia—Galantamine—Alzheimer's disease	0.000122	0.000999	CcSEcCtD
Felbamate—Erythema multiforme—Memantine—Alzheimer's disease	0.00012	0.000982	CcSEcCtD
Felbamate—Flatulence—Donepezil—Alzheimer's disease	0.00012	0.000981	CcSEcCtD
Felbamate—Hypotension—Galantamine—Alzheimer's disease	0.000119	0.00098	CcSEcCtD
Felbamate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000119	0.000979	CcSEcCtD
Felbamate—Tension—Donepezil—Alzheimer's disease	0.000119	0.000977	CcSEcCtD
Felbamate—Dysgeusia—Donepezil—Alzheimer's disease	0.000119	0.000975	CcSEcCtD
Felbamate—Nervousness—Donepezil—Alzheimer's disease	0.000118	0.000967	CcSEcCtD
Felbamate—Flushing—Memantine—Alzheimer's disease	0.000117	0.000964	CcSEcCtD
Felbamate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000117	0.00096	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000116	0.000955	CcSEcCtD
Felbamate—Insomnia—Galantamine—Alzheimer's disease	0.000116	0.000948	CcSEcCtD
Felbamate—Flushing—Rivastigmine—Alzheimer's disease	0.000115	0.000943	CcSEcCtD
Felbamate—Paraesthesia—Galantamine—Alzheimer's disease	0.000115	0.000941	CcSEcCtD
Felbamate—Tremor—Donepezil—Alzheimer's disease	0.000114	0.000933	CcSEcCtD
Felbamate—Somnolence—Galantamine—Alzheimer's disease	0.000114	0.000932	CcSEcCtD
Felbamate—Chills—Memantine—Alzheimer's disease	0.000114	0.000932	CcSEcCtD
Felbamate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000113	0.000924	CcSEcCtD
Felbamate—Dyspepsia—Galantamine—Alzheimer's disease	0.000112	0.000923	CcSEcCtD
Felbamate—Anaemia—Donepezil—Alzheimer's disease	0.000112	0.00092	CcSEcCtD
Felbamate—Alopecia—Memantine—Alzheimer's disease	0.000112	0.000918	CcSEcCtD
Felbamate—Agitation—Donepezil—Alzheimer's disease	0.000111	0.000915	CcSEcCtD
Felbamate—Chills—Rivastigmine—Alzheimer's disease	0.000111	0.000911	CcSEcCtD
Felbamate—Decreased appetite—Galantamine—Alzheimer's disease	0.000111	0.000911	CcSEcCtD
Felbamate—Fatigue—Galantamine—Alzheimer's disease	0.00011	0.000904	CcSEcCtD
Felbamate—Malaise—Donepezil—Alzheimer's disease	0.000109	0.000898	CcSEcCtD
Felbamate—Alopecia—Rivastigmine—Alzheimer's disease	0.000109	0.000898	CcSEcCtD
Felbamate—Constipation—Galantamine—Alzheimer's disease	0.000109	0.000896	CcSEcCtD
Felbamate—Flatulence—Memantine—Alzheimer's disease	0.000109	0.000891	CcSEcCtD
Felbamate—Tension—Memantine—Alzheimer's disease	0.000108	0.000887	CcSEcCtD
Felbamate—Dysgeusia—Memantine—Alzheimer's disease	0.000108	0.000885	CcSEcCtD
Felbamate—Nervousness—Memantine—Alzheimer's disease	0.000107	0.000878	CcSEcCtD
Felbamate—Flatulence—Rivastigmine—Alzheimer's disease	0.000106	0.000871	CcSEcCtD
Felbamate—Cough—Donepezil—Alzheimer's disease	0.000106	0.000869	CcSEcCtD
Felbamate—Tension—Rivastigmine—Alzheimer's disease	0.000106	0.000868	CcSEcCtD
Felbamate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000106	0.000866	CcSEcCtD
Felbamate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000105	0.000864	CcSEcCtD
Felbamate—Hypertension—Donepezil—Alzheimer's disease	0.000105	0.000859	CcSEcCtD
Felbamate—Nervousness—Rivastigmine—Alzheimer's disease	0.000105	0.000859	CcSEcCtD
Felbamate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000104	0.000857	CcSEcCtD
Felbamate—Myalgia—Donepezil—Alzheimer's disease	0.000103	0.000848	CcSEcCtD
Felbamate—Arthralgia—Donepezil—Alzheimer's disease	0.000103	0.000848	CcSEcCtD
Felbamate—Chest pain—Donepezil—Alzheimer's disease	0.000103	0.000848	CcSEcCtD
Felbamate—Tremor—Memantine—Alzheimer's disease	0.000103	0.000847	CcSEcCtD
Felbamate—Anxiety—Donepezil—Alzheimer's disease	0.000103	0.000845	CcSEcCtD
Felbamate—Ill-defined disorder—Memantine—Alzheimer's disease	0.000102	0.000839	CcSEcCtD
Felbamate—Discomfort—Donepezil—Alzheimer's disease	0.000102	0.000837	CcSEcCtD
Felbamate—Anaemia—Memantine—Alzheimer's disease	0.000102	0.000835	CcSEcCtD
Felbamate—Agitation—Memantine—Alzheimer's disease	0.000101	0.000831	CcSEcCtD
Felbamate—Dry mouth—Donepezil—Alzheimer's disease	0.000101	0.000829	CcSEcCtD
Felbamate—Abdominal pain—Galantamine—Alzheimer's disease	0.000101	0.000829	CcSEcCtD
Felbamate—Body temperature increased—Galantamine—Alzheimer's disease	0.000101	0.000829	CcSEcCtD
Felbamate—Tremor—Rivastigmine—Alzheimer's disease	0.000101	0.000828	CcSEcCtD
Felbamate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.0001	0.00082	CcSEcCtD
Felbamate—Confusional state—Donepezil—Alzheimer's disease	9.98e-05	0.000819	CcSEcCtD
Felbamate—Anaemia—Rivastigmine—Alzheimer's disease	9.96e-05	0.000817	CcSEcCtD
Felbamate—Malaise—Memantine—Alzheimer's disease	9.93e-05	0.000815	CcSEcCtD
Felbamate—Agitation—Rivastigmine—Alzheimer's disease	9.9e-05	0.000813	CcSEcCtD
Felbamate—Oedema—Donepezil—Alzheimer's disease	9.9e-05	0.000812	CcSEcCtD
Felbamate—Leukopenia—Memantine—Alzheimer's disease	9.86e-05	0.000809	CcSEcCtD
Felbamate—Infection—Donepezil—Alzheimer's disease	9.84e-05	0.000807	CcSEcCtD
Felbamate—Palpitations—Memantine—Alzheimer's disease	9.73e-05	0.000799	CcSEcCtD
Felbamate—Malaise—Rivastigmine—Alzheimer's disease	9.72e-05	0.000797	CcSEcCtD
Felbamate—Thrombocytopenia—Donepezil—Alzheimer's disease	9.69e-05	0.000795	CcSEcCtD
Felbamate—Cough—Memantine—Alzheimer's disease	9.61e-05	0.000789	CcSEcCtD
Felbamate—Hyperhidrosis—Donepezil—Alzheimer's disease	9.57e-05	0.000785	CcSEcCtD
Felbamate—Palpitations—Rivastigmine—Alzheimer's disease	9.52e-05	0.000781	CcSEcCtD
Felbamate—Hypertension—Memantine—Alzheimer's disease	9.51e-05	0.00078	CcSEcCtD
Felbamate—Anorexia—Donepezil—Alzheimer's disease	9.44e-05	0.000774	CcSEcCtD
Felbamate—Cough—Rivastigmine—Alzheimer's disease	9.4e-05	0.000772	CcSEcCtD
Felbamate—Myalgia—Memantine—Alzheimer's disease	9.38e-05	0.00077	CcSEcCtD
Felbamate—Arthralgia—Memantine—Alzheimer's disease	9.38e-05	0.00077	CcSEcCtD
Felbamate—Chest pain—Memantine—Alzheimer's disease	9.38e-05	0.00077	CcSEcCtD
Felbamate—Anxiety—Memantine—Alzheimer's disease	9.35e-05	0.000767	CcSEcCtD
Felbamate—Hypertension—Rivastigmine—Alzheimer's disease	9.3e-05	0.000763	CcSEcCtD
Felbamate—Discomfort—Memantine—Alzheimer's disease	9.27e-05	0.00076	CcSEcCtD
Felbamate—Hypotension—Donepezil—Alzheimer's disease	9.25e-05	0.000759	CcSEcCtD
Felbamate—Chest pain—Rivastigmine—Alzheimer's disease	9.17e-05	0.000753	CcSEcCtD
Felbamate—Arthralgia—Rivastigmine—Alzheimer's disease	9.17e-05	0.000753	CcSEcCtD
Felbamate—Myalgia—Rivastigmine—Alzheimer's disease	9.17e-05	0.000753	CcSEcCtD
Felbamate—Dry mouth—Memantine—Alzheimer's disease	9.17e-05	0.000753	CcSEcCtD
Felbamate—Asthenia—Galantamine—Alzheimer's disease	9.17e-05	0.000752	CcSEcCtD
Felbamate—Anxiety—Rivastigmine—Alzheimer's disease	9.14e-05	0.00075	CcSEcCtD
Felbamate—Confusional state—Memantine—Alzheimer's disease	9.06e-05	0.000744	CcSEcCtD
Felbamate—Discomfort—Rivastigmine—Alzheimer's disease	9.06e-05	0.000744	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.02e-05	0.00074	CcSEcCtD
Felbamate—Oedema—Memantine—Alzheimer's disease	8.99e-05	0.000738	CcSEcCtD
Felbamate—Dry mouth—Rivastigmine—Alzheimer's disease	8.97e-05	0.000736	CcSEcCtD
Felbamate—Insomnia—Donepezil—Alzheimer's disease	8.96e-05	0.000735	CcSEcCtD
Felbamate—Infection—Memantine—Alzheimer's disease	8.93e-05	0.000733	CcSEcCtD
Felbamate—Paraesthesia—Donepezil—Alzheimer's disease	8.89e-05	0.00073	CcSEcCtD
Felbamate—Confusional state—Rivastigmine—Alzheimer's disease	8.87e-05	0.000728	CcSEcCtD
Felbamate—Dyspnoea—Donepezil—Alzheimer's disease	8.83e-05	0.000724	CcSEcCtD
Felbamate—Somnolence—Donepezil—Alzheimer's disease	8.8e-05	0.000722	CcSEcCtD
Felbamate—Thrombocytopenia—Memantine—Alzheimer's disease	8.8e-05	0.000722	CcSEcCtD
Felbamate—Oedema—Rivastigmine—Alzheimer's disease	8.79e-05	0.000722	CcSEcCtD
Felbamate—Tachycardia—Memantine—Alzheimer's disease	8.77e-05	0.00072	CcSEcCtD
Felbamate—Diarrhoea—Galantamine—Alzheimer's disease	8.74e-05	0.000717	CcSEcCtD
Felbamate—Infection—Rivastigmine—Alzheimer's disease	8.74e-05	0.000717	CcSEcCtD
Felbamate—Dyspepsia—Donepezil—Alzheimer's disease	8.72e-05	0.000715	CcSEcCtD
Felbamate—Hyperhidrosis—Memantine—Alzheimer's disease	8.69e-05	0.000713	CcSEcCtD
Felbamate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	8.61e-05	0.000707	CcSEcCtD
Felbamate—Decreased appetite—Donepezil—Alzheimer's disease	8.61e-05	0.000706	CcSEcCtD
Felbamate—Tachycardia—Rivastigmine—Alzheimer's disease	8.58e-05	0.000704	CcSEcCtD
Felbamate—Anorexia—Memantine—Alzheimer's disease	8.57e-05	0.000703	CcSEcCtD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	8.55e-05	0.00143	CbGpPWpGaD
Felbamate—Fatigue—Donepezil—Alzheimer's disease	8.54e-05	0.0007	CcSEcCtD
Felbamate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.5e-05	0.000698	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—APH1A—Alzheimer's disease	8.5e-05	0.00142	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—GSK3B—Alzheimer's disease	8.48e-05	0.00142	CbGpPWpGaD
Felbamate—Pain—Donepezil—Alzheimer's disease	8.47e-05	0.000695	CcSEcCtD
Felbamate—Constipation—Donepezil—Alzheimer's disease	8.47e-05	0.000695	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	8.45e-05	0.00141	CbGpPWpGaD
Felbamate—Dizziness—Galantamine—Alzheimer's disease	8.45e-05	0.000693	CcSEcCtD
Felbamate—Hypotension—Memantine—Alzheimer's disease	8.4e-05	0.000689	CcSEcCtD
Felbamate—Anorexia—Rivastigmine—Alzheimer's disease	8.38e-05	0.000688	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	8.28e-05	0.00139	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—NCSTN—Alzheimer's disease	8.27e-05	0.00138	CbGpPWpGaD
Felbamate—Hypotension—Rivastigmine—Alzheimer's disease	8.22e-05	0.000674	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.19e-05	0.000672	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	8.17e-05	0.00137	CbGpPWpGaD
Felbamate—Feeling abnormal—Donepezil—Alzheimer's disease	8.16e-05	0.00067	CcSEcCtD
Felbamate—Insomnia—Memantine—Alzheimer's disease	8.13e-05	0.000667	CcSEcCtD
Felbamate—Vomiting—Galantamine—Alzheimer's disease	8.12e-05	0.000667	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—DPYSL2—Alzheimer's disease	8.11e-05	0.00136	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.1e-05	0.000664	CcSEcCtD
Felbamate—Paraesthesia—Memantine—Alzheimer's disease	8.07e-05	0.000662	CcSEcCtD
Felbamate—Rash—Galantamine—Alzheimer's disease	8.06e-05	0.000661	CcSEcCtD
Felbamate—Dermatitis—Galantamine—Alzheimer's disease	8.05e-05	0.00066	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—CYP46A1—Alzheimer's disease	8.04e-05	0.00135	CbGpPWpGaD
Felbamate—Dyspnoea—Memantine—Alzheimer's disease	8.01e-05	0.000658	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.01e-05	0.000657	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—ACHE—Alzheimer's disease	8.01e-05	0.00134	CbGpPWpGaD
Felbamate—Headache—Galantamine—Alzheimer's disease	8e-05	0.000657	CcSEcCtD
Felbamate—Somnolence—Memantine—Alzheimer's disease	7.99e-05	0.000656	CcSEcCtD
Felbamate—Insomnia—Rivastigmine—Alzheimer's disease	7.95e-05	0.000653	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	7.93e-05	0.00133	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CHRNA4—Alzheimer's disease	7.92e-05	0.00132	CbGpPWpGaD
Felbamate—Dyspepsia—Memantine—Alzheimer's disease	7.91e-05	0.000649	CcSEcCtD
Felbamate—Paraesthesia—Rivastigmine—Alzheimer's disease	7.9e-05	0.000648	CcSEcCtD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	7.89e-05	0.00132	CbGpPWpGaD
Felbamate—Urticaria—Donepezil—Alzheimer's disease	7.87e-05	0.000645	CcSEcCtD
Felbamate—Dyspnoea—Rivastigmine—Alzheimer's disease	7.84e-05	0.000643	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—GRIA1—Alzheimer's disease	7.83e-05	0.00131	CbGpPWpGaD
Felbamate—Body temperature increased—Donepezil—Alzheimer's disease	7.83e-05	0.000642	CcSEcCtD
Felbamate—Abdominal pain—Donepezil—Alzheimer's disease	7.83e-05	0.000642	CcSEcCtD
Felbamate—Somnolence—Rivastigmine—Alzheimer's disease	7.82e-05	0.000642	CcSEcCtD
Felbamate—Decreased appetite—Memantine—Alzheimer's disease	7.81e-05	0.000641	CcSEcCtD
Felbamate—Fatigue—Memantine—Alzheimer's disease	7.75e-05	0.000636	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	7.74e-05	0.0013	CbGpPWpGaD
Felbamate—Dyspepsia—Rivastigmine—Alzheimer's disease	7.74e-05	0.000635	CcSEcCtD
Felbamate—GRIN2B—Reelin signaling pathway—AKT1—Alzheimer's disease	7.73e-05	0.00129	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BDNF—Alzheimer's disease	7.71e-05	0.00129	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EPHA1—Alzheimer's disease	7.69e-05	0.00129	CbGpPWpGaD
Felbamate—Pain—Memantine—Alzheimer's disease	7.69e-05	0.000631	CcSEcCtD
Felbamate—Constipation—Memantine—Alzheimer's disease	7.69e-05	0.000631	CcSEcCtD
Felbamate—Decreased appetite—Rivastigmine—Alzheimer's disease	7.65e-05	0.000627	CcSEcCtD
Felbamate—Nausea—Galantamine—Alzheimer's disease	7.59e-05	0.000623	CcSEcCtD
Felbamate—Fatigue—Rivastigmine—Alzheimer's disease	7.58e-05	0.000622	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	7.56e-05	0.00126	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	7.54e-05	0.00126	CbGpPWpGaD
Felbamate—Constipation—Rivastigmine—Alzheimer's disease	7.52e-05	0.000617	CcSEcCtD
Felbamate—Pain—Rivastigmine—Alzheimer's disease	7.52e-05	0.000617	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—CHRNB2—Alzheimer's disease	7.41e-05	0.00124	CbGpPWpGaD
Felbamate—Feeling abnormal—Memantine—Alzheimer's disease	7.41e-05	0.000608	CcSEcCtD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—Alzheimer's disease	7.35e-05	0.00123	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Memantine—Alzheimer's disease	7.35e-05	0.000603	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—Alzheimer's disease	7.34e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—CASP3—Alzheimer's disease	7.33e-05	0.00123	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	7.31e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	7.31e-05	0.00122	CbGpPWpGaD
Felbamate—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.25e-05	0.000595	CcSEcCtD
Felbamate—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	7.2e-05	0.00121	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.19e-05	0.00059	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	7.19e-05	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MEF2C—Alzheimer's disease	7.16e-05	0.0012	CbGpPWpGaD
Felbamate—Urticaria—Memantine—Alzheimer's disease	7.14e-05	0.000586	CcSEcCtD
Felbamate—Abdominal pain—Memantine—Alzheimer's disease	7.11e-05	0.000583	CcSEcCtD
Felbamate—Body temperature increased—Memantine—Alzheimer's disease	7.11e-05	0.000583	CcSEcCtD
Felbamate—Asthenia—Donepezil—Alzheimer's disease	7.1e-05	0.000583	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—CDK5—Alzheimer's disease	7.03e-05	0.00118	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	7.02e-05	0.00118	CbGpPWpGaD
Felbamate—Pruritus—Donepezil—Alzheimer's disease	7e-05	0.000575	CcSEcCtD
Felbamate—Urticaria—Rivastigmine—Alzheimer's disease	6.99e-05	0.000573	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—BCHE—Alzheimer's disease	6.98e-05	0.00117	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	6.97e-05	0.00117	CbGpPWpGaD
Felbamate—Body temperature increased—Rivastigmine—Alzheimer's disease	6.95e-05	0.00057	CcSEcCtD
Felbamate—Abdominal pain—Rivastigmine—Alzheimer's disease	6.95e-05	0.00057	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—PRNP—Alzheimer's disease	6.95e-05	0.00116	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—NGF—Alzheimer's disease	6.84e-05	0.00115	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	6.84e-05	0.00115	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—ACHE—Alzheimer's disease	6.81e-05	0.00114	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—DLG4—Alzheimer's disease	6.81e-05	0.00114	CbGpPWpGaD
Felbamate—Diarrhoea—Donepezil—Alzheimer's disease	6.77e-05	0.000556	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—CHRNA4—Alzheimer's disease	6.73e-05	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PSEN2—Alzheimer's disease	6.73e-05	0.00113	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	6.71e-05	0.00112	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—GRIN2B—Alzheimer's disease	6.66e-05	0.00111	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—PLCB1—Alzheimer's disease	6.58e-05	0.0011	CbGpPWpGaD
Felbamate—Dizziness—Donepezil—Alzheimer's disease	6.55e-05	0.000537	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—CALM1—Alzheimer's disease	6.54e-05	0.00109	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—APOE—Alzheimer's disease	6.52e-05	0.00109	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	6.48e-05	0.00108	CbGpPWpGaD
Felbamate—Asthenia—Memantine—Alzheimer's disease	6.45e-05	0.000529	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	6.39e-05	0.00107	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	6.39e-05	0.00107	CbGpPWpGaD
Felbamate—Pruritus—Memantine—Alzheimer's disease	6.36e-05	0.000522	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	6.35e-05	0.00106	CbGpPWpGaD
Felbamate—Asthenia—Rivastigmine—Alzheimer's disease	6.31e-05	0.000518	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	6.3e-05	0.00105	CbGpPWpGaD
Felbamate—Vomiting—Donepezil—Alzheimer's disease	6.3e-05	0.000517	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	6.26e-05	0.00105	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—Alzheimer's disease	6.24e-05	0.00104	CbGpPWpGaD
Felbamate—Rash—Donepezil—Alzheimer's disease	6.24e-05	0.000512	CcSEcCtD
Felbamate—Dermatitis—Donepezil—Alzheimer's disease	6.24e-05	0.000512	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—CASP3—Alzheimer's disease	6.23e-05	0.00104	CbGpPWpGaD
Felbamate—Pruritus—Rivastigmine—Alzheimer's disease	6.22e-05	0.000511	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	6.22e-05	0.00104	CbGpPWpGaD
Felbamate—Headache—Donepezil—Alzheimer's disease	6.2e-05	0.000509	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—CYP46A1—Alzheimer's disease	6.2e-05	0.00104	CbGpPWpGaD
Felbamate—Diarrhoea—Memantine—Alzheimer's disease	6.15e-05	0.000505	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—PSENEN—Alzheimer's disease	6.15e-05	0.00103	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP46A1—Alzheimer's disease	6.12e-05	0.00102	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—APH1A—Alzheimer's disease	6.06e-05	0.00101	CbGpPWpGaD
Felbamate—Diarrhoea—Rivastigmine—Alzheimer's disease	6.02e-05	0.000494	CcSEcCtD
Felbamate—Dizziness—Memantine—Alzheimer's disease	5.94e-05	0.000488	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—BCHE—Alzheimer's disease	5.93e-05	0.000993	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NCSTN—Alzheimer's disease	5.9e-05	0.000988	CbGpPWpGaD
Felbamate—Nausea—Donepezil—Alzheimer's disease	5.88e-05	0.000483	CcSEcCtD
Felbamate—Dizziness—Rivastigmine—Alzheimer's disease	5.82e-05	0.000477	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—DLG4—Alzheimer's disease	5.79e-05	0.000969	CbGpPWpGaD
Felbamate—Vomiting—Memantine—Alzheimer's disease	5.72e-05	0.000469	CcSEcCtD
Felbamate—Rash—Memantine—Alzheimer's disease	5.67e-05	0.000465	CcSEcCtD
Felbamate—Dermatitis—Memantine—Alzheimer's disease	5.66e-05	0.000465	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	5.64e-05	0.000945	CbGpPWpGaD
Felbamate—Headache—Memantine—Alzheimer's disease	5.63e-05	0.000462	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—PLCB1—Alzheimer's disease	5.6e-05	0.000937	CbGpPWpGaD
Felbamate—Vomiting—Rivastigmine—Alzheimer's disease	5.59e-05	0.000459	CcSEcCtD
Felbamate—Rash—Rivastigmine—Alzheimer's disease	5.55e-05	0.000455	CcSEcCtD
Felbamate—Dermatitis—Rivastigmine—Alzheimer's disease	5.54e-05	0.000455	CcSEcCtD
Felbamate—Headache—Rivastigmine—Alzheimer's disease	5.51e-05	0.000452	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.5e-05	0.00092	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	5.4e-05	0.000904	CbGpPWpGaD
Felbamate—Nausea—Memantine—Alzheimer's disease	5.34e-05	0.000438	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TNF—Alzheimer's disease	5.33e-05	0.000892	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	5.32e-05	0.000891	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.28e-05	0.000884	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—GSK3B—Alzheimer's disease	5.25e-05	0.000878	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	5.25e-05	0.000878	CbGpPWpGaD
Felbamate—Nausea—Rivastigmine—Alzheimer's disease	5.22e-05	0.000429	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—CREB1—Alzheimer's disease	5.2e-05	0.000871	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	5.18e-05	0.000867	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—DLG4—Alzheimer's disease	5.14e-05	0.00086	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PRNP—Alzheimer's disease	4.96e-05	0.000829	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—PRKCG—Alzheimer's disease	4.87e-05	0.000815	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PSEN2—Alzheimer's disease	4.8e-05	0.000803	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—MAOB—Alzheimer's disease	4.8e-05	0.000803	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	4.75e-05	0.000794	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.71e-05	0.000788	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—Alzheimer's disease	4.7e-05	0.000786	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	4.67e-05	0.000782	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—Alzheimer's disease	4.6e-05	0.00077	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—Alzheimer's disease	4.53e-05	0.000758	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ADAM10—Alzheimer's disease	4.53e-05	0.000757	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IAPP—Alzheimer's disease	4.39e-05	0.000735	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CALM1—Alzheimer's disease	4.21e-05	0.000705	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	4.19e-05	0.000701	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—PRKCG—Alzheimer's disease	4.14e-05	0.000693	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4e-05	0.00067	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—Alzheimer's disease	3.99e-05	0.000668	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—Alzheimer's disease	3.85e-05	0.000645	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	3.84e-05	0.000643	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	3.79e-05	0.000634	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	3.73e-05	0.000624	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—MAOB—Alzheimer's disease	3.7e-05	0.000619	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	3.68e-05	0.000616	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—DLG4—Alzheimer's disease	3.67e-05	0.000614	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—PTGS1—Alzheimer's disease	3.64e-05	0.000608	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CREB1—Alzheimer's disease	3.61e-05	0.000603	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CALM1—Alzheimer's disease	3.58e-05	0.000599	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	3.57e-05	0.000597	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP2D6—Alzheimer's disease	3.57e-05	0.000597	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK8—Alzheimer's disease	3.54e-05	0.000593	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.52e-05	0.000588	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ADAM10—Alzheimer's disease	3.23e-05	0.000541	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	3.18e-05	0.000531	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	3.11e-05	0.000521	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CREB1—Alzheimer's disease	3.07e-05	0.000513	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	3.01e-05	0.000503	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARGC1A—Alzheimer's disease	2.96e-05	0.000496	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	2.89e-05	0.000483	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	2.8e-05	0.000469	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	2.75e-05	0.00046	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—GSK3B—Alzheimer's disease	2.74e-05	0.000459	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—CREB1—Alzheimer's disease	2.72e-05	0.000455	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.71e-05	0.000454	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—LPL—Alzheimer's disease	2.7e-05	0.000451	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MEF2C—Alzheimer's disease	2.67e-05	0.000447	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	2.58e-05	0.000432	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	2.38e-05	0.000399	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—LEP—Alzheimer's disease	2.26e-05	0.000378	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	2.23e-05	0.000372	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—Alzheimer's disease	2.09e-05	0.000349	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—Alzheimer's disease	2.09e-05	0.000349	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	2.06e-05	0.000345	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARG—Alzheimer's disease	1.97e-05	0.000329	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—GSK3B—Alzheimer's disease	1.96e-05	0.000327	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CREB1—Alzheimer's disease	1.94e-05	0.000325	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—INS—Alzheimer's disease	1.93e-05	0.000323	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA4—Alzheimer's disease	1.75e-05	0.000293	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—Alzheimer's disease	1.71e-05	0.000286	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	1.69e-05	0.000282	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	1.65e-05	0.000277	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	1.65e-05	0.000276	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.63e-05	0.000273	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	1.59e-05	0.000266	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	1.56e-05	0.000261	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLD3—Alzheimer's disease	1.49e-05	0.000249	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.48e-05	0.000248	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	1.43e-05	0.000239	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	1.37e-05	0.00023	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA4—Alzheimer's disease	1.35e-05	0.000226	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ND1—Alzheimer's disease	1.33e-05	0.000222	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.32e-05	0.000221	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	1.27e-05	0.000213	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—Alzheimer's disease	1.22e-05	0.000204	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	1.2e-05	0.000202	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—Alzheimer's disease	1.18e-05	0.000198	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLD3—Alzheimer's disease	1.15e-05	0.000192	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.15e-05	0.000192	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.14e-05	0.00019	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TGFB1—Alzheimer's disease	1.12e-05	0.000187	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.1e-05	0.000184	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.08e-05	0.00018	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.06e-05	0.000178	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—Alzheimer's disease	1.05e-05	0.000175	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.02e-05	0.000171	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1e-05	0.000168	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	9.56e-06	0.00016	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	9.16e-06	0.000153	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CHAT—Alzheimer's disease	8.56e-06	0.000143	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TPI1—Alzheimer's disease	8.56e-06	0.000143	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—Alzheimer's disease	8.43e-06	0.000141	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MAOB—Alzheimer's disease	8.2e-06	0.000137	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA4—Alzheimer's disease	8.13e-06	0.000136	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	7.9e-06	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.89e-06	0.000132	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—Alzheimer's disease	7.78e-06	0.00013	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	7.64e-06	0.000128	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—A2M—Alzheimer's disease	7.63e-06	0.000128	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	7.25e-06	0.000121	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.19e-06	0.00012	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLD3—Alzheimer's disease	6.91e-06	0.000116	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACHE—Alzheimer's disease	6.63e-06	0.000111	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	6.63e-06	0.000111	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CHAT—Alzheimer's disease	6.6e-06	0.00011	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TPI1—Alzheimer's disease	6.6e-06	0.00011	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	6.56e-06	0.00011	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	6.38e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MAOB—Alzheimer's disease	6.33e-06	0.000106	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ENO1—Alzheimer's disease	6.22e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	6.22e-06	0.000104	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ND1—Alzheimer's disease	6.16e-06	0.000103	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	6.1e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	6.09e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.02e-06	0.000101	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.97e-06	9.99e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—A2M—Alzheimer's disease	5.88e-06	9.85e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BCHE—Alzheimer's disease	5.78e-06	9.67e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	5.45e-06	9.13e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	5.29e-06	8.85e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.25e-06	8.78e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACHE—Alzheimer's disease	5.12e-06	8.57e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	5.06e-06	8.47e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO1—Alzheimer's disease	4.8e-06	8.03e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	4.8e-06	8.03e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	4.7e-06	7.87e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	4.56e-06	7.63e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	4.54e-06	7.59e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BCHE—Alzheimer's disease	4.46e-06	7.46e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4.21e-06	7.04e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LPL—Alzheimer's disease	4.15e-06	6.94e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.13e-06	6.91e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.08e-06	6.83e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.97e-06	6.64e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.97e-06	6.64e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.81e-06	6.37e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	3.73e-06	6.25e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.66e-06	6.13e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.54e-06	5.92e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	3.52e-06	5.88e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.5e-06	5.86e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CALM1—Alzheimer's disease	3.49e-06	5.84e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APOE—Alzheimer's disease	3.48e-06	5.82e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAV1—Alzheimer's disease	3.45e-06	5.77e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.2e-06	5.36e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.08e-06	5.15e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.04e-06	5.09e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.03e-06	5.07e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—INS—Alzheimer's disease	2.97e-06	4.97e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.88e-06	4.83e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.88e-06	4.83e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.88e-06	4.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.83e-06	4.73e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.69e-06	4.51e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.68e-06	4.49e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.68e-06	4.49e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.66e-06	4.45e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.6e-06	4.36e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.53e-06	4.23e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.45e-06	4.1e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	2.38e-06	3.99e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.34e-06	3.91e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—INS—Alzheimer's disease	2.29e-06	3.84e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.11e-06	3.54e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.1e-06	3.52e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.01e-06	3.36e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.92e-06	3.22e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.84e-06	3.08e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	2.9e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.62e-06	2.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.61e-06	2.7e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.6e-06	2.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.41e-06	2.35e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—INS—Alzheimer's disease	1.38e-06	2.31e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.21e-06	2.02e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.2e-06	2e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.85e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9.24e-07	1.55e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.56e-07	9.3e-06	CbGpPWpGaD
